Adiponectin inhibits oxidized low density lipoprotein-induced increase in matrix metalloproteinase ۹ expression in vascular smooth muscle cells

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 142

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RYA-11-3_005

تاریخ نمایه سازی: 2 شهریور 1401

Abstract:

BACKGROUND: High expression of matrix metalloproteinase ۹ (MMP۹) during vascular injury and inflammation plays an important role in atherosclerotic plaque formation and rupture. In the process of atherosclerosis, oxidized low-density lipoprotein (oxLDL) upregulates MMP۹ in human aortic vascular smooth muscle cells (HA/VSMCs). Adiponectin is an adipose tissue-derived hormone that has been shown to exert anti-atherogenic and anti-inflammatory effects. The aim of this study was to investigate the effect of adiponectin on MMP۹ expression under pathogenic condition created by oxLDL in HA/VSMCs. METHODS: In this experimental study, HA/VSMC were stimulated with oxLDL alone and in the presence of adiponectin for ۲۴ and ۴۸ h. The expression of MMP۹ gene was determined by real-time polymerase chain reaction method. The protein level of this gene was investigated by western blotting technique. RESULTS: An oxLDL increased MMP۹ expression ۲.۱۶ ± ۰.۲۴- and ۳.۳۲ ± ۰.۲۵-fold after ۲۴ and ۴۸ h, respectively and adiponectin decreased oxLDL-induced MMP۹ expression in a time-dependent manner. CONCLUSION: These results show that adiponectin changes extracellular matrix by reducing MMP۹ mRNA and protein, therefore, may stabilize lesions and reduce atheroma rupture. 

Keywords:

Matrix Metalloproteinase ۹ , Adiponectin , Oxidized Low Density Lipoprotein

Authors

Maryam Saneipour

MSc Student, Clinical Biochemistry Research Center, Shahrekord University of Medical Science, Shahrekord, Iran

Keihan Ghatreh-Samani

Assistant Professor, Clinical Biochemistry Research Center, Shahrekord University of Medical Science, Shahrekord, Iran

Esfandiar Heydarian

Associate Professor, Clinical Biochemistry Research Center, Shahrekord University of Medical Science, Shahrekord, Iran

Effat Farrokhi

PhD Candidate, Cellular and Molecular Research Center, Shahrekord University of Medical Science, Shahrekord, Iran

Narges Abdian

PhD Candidate, Cellular and Molecular Research Center, Shahrekord University of Medical Science, Shahrekord, Iran